Please use this identifier to cite or link to this item:
https://doi.org/10.1186/gm388
DC Field | Value | |
---|---|---|
dc.title | Predicting cancer drivers: are we there yet? | |
dc.contributor.author | Krishnan, V.G | |
dc.contributor.author | Ng, P.C | |
dc.date.accessioned | 2020-10-28T07:28:27Z | |
dc.date.available | 2020-10-28T07:28:27Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Krishnan, V.G, Ng, P.C (2012). Predicting cancer drivers: are we there yet?. Genome Medicine 4 (11) : 88. ScholarBank@NUS Repository. https://doi.org/10.1186/gm388 | |
dc.identifier.issn | 1756994X | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/181841 | |
dc.description.abstract | Genomic variants with a key role in causing cancer or affecting the response to cancertherapeutics need to be identified so that they can be targeted for therapy. The transFIC tool aimsto identify somatic point mutations that drive cancer in sequencing projects. This package isavailable as a web service, a stand-alone program and a website. It improves the functionalprediction scores generated by popular established prediction tools and will be useful to cancerresearchers.See research article: http://genomemedicine.com/content/4/11/89. © 2012 BioMed Central Ltd. | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Unpaywall 20201031 | |
dc.subject | B Raf kinase | |
dc.subject | cetuximab | |
dc.subject | panitumumab | |
dc.subject | protein p53 | |
dc.subject | cancer cell | |
dc.subject | cancer research | |
dc.subject | cancer therapy | |
dc.subject | cell cycle | |
dc.subject | colorectal cancer | |
dc.subject | cost | |
dc.subject | driver mutation | |
dc.subject | drug sensitivity | |
dc.subject | gene function | |
dc.subject | gene mutation | |
dc.subject | gene product | |
dc.subject | gene sequence | |
dc.subject | genetic correlation | |
dc.subject | genetic variability | |
dc.subject | germ line | |
dc.subject | human | |
dc.subject | loss of function mutation | |
dc.subject | melanoma | |
dc.subject | metastasis | |
dc.subject | missense mutation | |
dc.subject | neoplasm | |
dc.subject | note | |
dc.subject | nucleic acid base substitution | |
dc.subject | oncogene K ras | |
dc.subject | passenger mutation | |
dc.subject | point mutation | |
dc.subject | prediction | |
dc.subject | priority journal | |
dc.subject | protein function | |
dc.subject | scientist | |
dc.subject | single nucleotide polymorphism | |
dc.subject | somatic mutation | |
dc.subject | treatment outcome | |
dc.subject | tumor growth | |
dc.type | Note | |
dc.contributor.department | MEDICINE | |
dc.description.doi | 10.1186/gm388 | |
dc.description.sourcetitle | Genome Medicine | |
dc.description.volume | 4 | |
dc.description.issue | 11 | |
dc.description.page | 88 | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1186_gm388.pdf | 135.65 kB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License